2m 2m 2m 2m 2m 2m 2m
COGNITION THERAP (CGTX)
NASDAQ
$1.43+$0.005 (+0.35%)
Price as of Jun 03, 2026 7:57 PM EDT- $105.6MMarket Cap
- 335.62%1-Year Change
- BiotechnologyIndustry
COGNITION THERAP (CGTX)
$1.43+$0.005 (+0.35%)
CGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.42 | ||
Change | +$0.10 (+8.00%) | ||
Open | $1.34 | ||
High | $1.46 | ||
Low | $1.26 | ||
Previous Close | $1.35 | ||
Volume | 2,210,673 | ||
30-Day Average Volume | 1,000,125 | ||
1-Week Change | 8.87% | ||
1-Month Change | 5.47% | ||
1-Year Change | 335.62% | ||
3-Year Change | -51.61% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 89.5M | ||
Total Assets | $36.1M | ||
Market Cap | $105.6M | ||
Enterprise Value | $74.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.6M | ||
Free Cash Flow | -$5.5M | ||
EBIT | -$4.6M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $29.8M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -24 | ||
PEG | 1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue